An obvious trend was also shown in Fig. 7E and 7G that CESC patients or cervical adenocarcinoma patients from TCGA database with lower PLK1 expression experienced longer event-free survival time than those with higher PLK1 expression, though the results was not statistically significant. The gene discussed is PLK1; the disease is cervical adenocarcinoma.